Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$42 | -$51 | $7 |
| Dep. & Amort. | $0 | -$1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $4 | $5 |
| Change in WC | -$10 | -$4 | -$0 | -$12 |
| Other Non-Cash | -$6 | -$3 | -$2 | -$47 |
| Operating Cash Flow | -$49 | -$46 | -$49 | -$46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$150 | -$19 | -$25 | -$70 |
| Inv. Sales/Matur. | $55 | $69 | $69 | $65 |
| Other Inv. Act. | $0 | $0 | -$1 | $65 |
| Investing Cash Flow | -$95 | $50 | $44 | $60 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $142 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $142 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$2 | $4 | -$5 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43 | $39 | $44 | $30 |
| End Cash | $41 | $43 | $39 | $44 |
| Free Cash Flow | -$49 | -$46 | -$49 | -$47 |